🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
A study evaluating the safety, preliminary efficacy and pharmacokinetics of...
Status
Terminated
Location
HOPITAL JEAN MINJOZ; Oncologie
Start Date
2020-07-09
Trial ID
NCT04404140
Treatments Being Tested
Basket trial concept to independently and simultaneously assess the effects...
Status
Active Not Recruiting
Location
Institut Bergonié
Start Date
2021-03-31
Trial ID
NCT03915678
This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey
Start Date
2019-09-11
Trial ID
NCT04081688
Treatments Being Tested
This is a single arm, Phase II trial involving the use of atezolizumab plus...
Status
Recruiting
Location
Johns Hopkins University: Sibley Memorial Hospital
Start Date
2022-06-27
Trial ID
NCT05312671
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This is an open-label phase II study assessing the activity of cabozantinib...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2020-05-21
Trial ID
NCT04289779
Treatments Being Tested
This is an open-label, multicenter, dose-escalation and expansion Phase Ib ...
Status
Completed
Location
UCLA Cancer Center
Start Date
2016-01-07
Trial ID
NCT02650713
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994